Quick Answer
Encompass Health Corp reported Diluted EPS of $5.54 per share for fiscal year 2025.
Encompass Health Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $5.54 | +24.2% |
| 2024 | $4.46 | +28.5% |
| 2023 | $3.47 | +28.5% |
| 2022 | $2.70 | -34.3% |
| 2021 | $4.11 | +44.2% |
| 2020 | $2.85 | -21.1% |
| 2019 | $3.61 | +23.2% |
| 2018 | $2.93 | +3.2% |
| 2017 | $2.84 | +9.7% |
| 2016 | $2.59 | +35.6% |
| 2015 | $1.91 | -16.6% |
| 2014 | $2.29 | -11.2% |
| 2013 | $2.58 | +54.5% |
| 2012 | $1.67 | -14.8% |
| 2011 | $1.96 | -76.3% |
| 2010 | $8.28 | +975.3% |
| 2009 | $0.77 | -70.6% |
| 2008 | $2.62 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.24 | +17.0% | -10.8% |
| June 30, 2025 | $1.39 | +24.1% | -6.1% |
| March 31, 2025 | $1.48 | +34.5% | +39.6% |
| September 30, 2024 | $1.06 | +26.2% | -5.4% |
| June 30, 2024 | $1.12 | +24.4% | +1.8% |
| March 31, 2024 | $1.10 | +26.4% | +31.0% |
| September 30, 2023 | $0.84 | +86.7% | -6.7% |
| June 30, 2023 | $0.90 | +83.7% | +3.4% |
- Encompass Health Corp showed an increase of +24.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, Encompass Health Corp’s diluted eps has grown by 111.5% (from $2.62 per share to $5.54 per share).
- The most recent figure is from Encompass Health Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: